For more than 50 years, I-131 has been recognized as an effective tool for
controlling thyroid hyperplasia and hyperactivity. The fixed dose administr
ation is the simplest method with doses of 111-370 MBq (3 to 10 mCi) I-131
being administered. More sophisticated methods aiming to deliver a well-def
ined amount of I-131 per gram of thyroid tissue are handicapped by problems
related to the evaluation of the goiter size and the prediction of the sen
sitivity of thyroid cells to radiation. The use of I-131 in nontoxic multin
odular goiter is to be reserved for specific situations.